diazoxide has been researched along with Benign Neoplasms, Brain in 1 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YS | 1 |
| Sayeed, MM | 1 |
| Wurster, RD | 1 |
1 other study available for diazoxide and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Inhibition of cell growth by K+ channel modulators is due to interference with agonist-induced Ca2+ release.
Topics: 4-Aminopyridine; Astrocytoma; Brain Neoplasms; Calcium; Cell Division; Diazoxide; Humans; In Vitro T | 1993 |